Novel RNA Modality for Translation in Eukaryotic Cells
Disclosed are methods and constructs for engineering circular RNA Disclosed is a vector for making circular RNA, said vector comprising the following elements operably connected to each other and arranged in the following sequence: a) a 5′ homology arm, b) a 3′ group I intron fragment containing a 3′ splice site dinucleotide, c) an optional 5′ spacer sequence, d) a protein coding or noncoding region, e) an optional 3′ spacer sequence, f) a 5′ Group I intron fragment containing a 5′ splice site dinucleotide, and g) a 3′ homology arm. This vector allows production of a circular RNA that is translatable or biologically active inside eukaryotic cells. In one embodiment, the vector can comprise the 5′ spacer sequence, but not the 3′ spacer sequence. In yet another embodiment, the vector can also comprise the 3′ spacer sequence, but not the 5′ spacer sequence.
Researchers
-
circular rna for translation in eukaryotic cells
China | Published application -
circular rna for translation in eukaryotic cells
United States of America | Granted | 11,981,909 -
circular rna for translation in eukaryotic cells
Japan | Published application -
circular rna for translation in eukaryotic cells
Australia | Granted | 2,019,280,583 -
circular rna for translation in eukaryotic cells
Canada | Published application -
circular rna for translation in eukaryotic cells
European Patent Convention | Published application -
circular rna for translation in eukaryotic cells
Korea (south) | Published application -
circular rna for translation in eukaryotic cells
China | Granted | 112,399,860 -
circular rna for translation in eukaryotic cells
Mexico | Published application -
circular rna for translation in eukaryotic cells
Israel | Pending -
circular rna for translation in eukaryotic cells
Brazil | Published application -
circular rna for translation in eukaryotic cells
Singapore | Pending -
circular rna for translation in eukaryotic cells
Israel | Pending -
circular rna for translation in eukaryotic cells
United States of America | Granted | 11,203,767 -
circular rna for translation in eukaryotic cells
Hong Kong | Granted | 40,038,458 -
circular rna for translation in eukaryotic cells
United States of America | Granted | 11,447,796 -
novel rna modality for translation in eukaryotic cells
United States of America | Granted | 11,845,950 -
circular rna for translation in eukaryotic cells
Hong Kong | Published application -
circular rna for translation in eukaryotic cells
United States of America | Granted | 11,352,640 -
circular rna for translation in eukaryotic cells
Australia | Pending -
circular rna for translation in eukaryotic cells
United States of America | Published application -
circular rna for translation in eukaryotic cells
United States of America | Granted | 11,352,641 -
circular rna for translation in eukaryotic cells
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.